|
1
|
Carcas LP: Gastric cancer review. J
Carcinog. 13:142014. View Article : Google Scholar
|
|
2
|
Parkin DM, Ferlay J, Curado MP, Bray F,
Edwards B, Shin HR and Forman D: Fifty years of cancer incidence:
CI5 I-IX. Int J Cancer. 127:2918–2927. 2010. View Article : Google Scholar
|
|
3
|
Lee AJ, Endesfelder D, Rowan AJ, Walther
A, Birkbak NJ, Futreal PA, Downward J, Szallasi Z, Tomlinson IP,
Howell M, et al: Chromosomal instability confers intrinsic
multidrug resistance. Cancer Res. 71:1858–1870. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Simons K and Toomre D: Lipid rafts and
signal transduction. Nat Rev Mol Cell Biol. 1:31–39. 2000.
View Article : Google Scholar
|
|
5
|
Hemler ME: Targeting of tetraspanin
proteins - potential benefits and strategies. Nat Rev Drug Discov.
7:747–758. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Claas C, Stipp CS and Hemler ME:
Evaluation of prototype transmembrane 4 superfamily protein
complexes and their relation to lipid rafts. J Biol Chem.
276:7974–7984. 2001. View Article : Google Scholar
|
|
7
|
Yáñez-Mó M, Barreiro O, Gordon-Alonso M,
Sala-Valdés M and Sánchez-Madrid F: Tetraspanin-enriched
microdomains: A functional unit in cell plasma membranes. Trends
Cell Biol. 19:434–446. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mazzocca A, Birgani MT, Sabbà C and
Carloni V: Tetraspanin-enriched microdomains and hepatocellular
carcinoma progression. Cancer Lett. 351:23–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zöller M: Tetraspanins: Push and pull in
suppressing and promoting metastasis. Nat Rev Cancer. 9:40–55.
2009. View
Article : Google Scholar
|
|
10
|
Kovalenko OV, Metcalf DG, DeGrado WF and
Hemler ME: Structural organization and interactions of
transmembrane domains in tetraspanin proteins. BMC Struct Biol.
5:112005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Protty MB, Watkins NA, Colombo D, Thomas
SG, Heath VL, Herbert JM, Bicknell R, Senis YA, Ashman LK,
Berditchevski F, et al: Identification of Tspan9 as a novel
platelet tetraspanin and the collagen receptor GPVI as a component
of tetraspanin microdomains. Biochem J. 417:391–400. 2009.
View Article : Google Scholar :
|
|
12
|
Sadej R, Grudowska A, Turczyk L, Kordek R
and Romanska HM: CD151 in cancer progression and metastasis: A
complex scenario. Lab Invest. 94:41–51. 2014. View Article : Google Scholar
|
|
13
|
Murayama Y, Oritani K and Tsutsui S: Novel
CD9-targeted therapies in gastric cancer. World J Gastroenterol.
21:3206–3213. 2015.PubMed/NCBI
|
|
14
|
Cakarovski K, Leung JY, Restall C,
Carin-Carlson A, Yang E, Perlmutter P, Anderson R, Medcalf R and
Dear AE: Novel inhibitors of urokinase-type plasminogen activator
and matrix metalloproteinase expression in metastatic cancer cell
lines. Int J Cancer. 110:610–616. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Toda D, Ota T, Tsukuda K, Watanabe K,
Fujiyama T, Murakami M, Naito M and Shimizu N: Gefitinib decreases
the synthesis of matrix metalloproteinase and the adhesion to
extracellular matrix proteins of colon cancer cells. Anticancer
Res. 26:129–134. 2006.PubMed/NCBI
|
|
16
|
Yang SF, Hsieh YS, Lin CL, Hsu NY, Chiou
HL, Chou FP and Chu SC: Increased plasma levels of urokinase
plasminogen activator and matrix metalloproteinase-9 in nonsmall
cell lung cancer patients. Clin Chim Acta. 354:91–99. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mook OR, Frederiks WM and Van Noorden CJ:
The role of gelatinases in colorectal cancer progression and
metastasis. Biochim Biophys Acta. 1705:69–89. 2004.PubMed/NCBI
|
|
18
|
Hwang ES and Lee HJ: Benzyl isothiocyanate
inhibits metalloproteinase-2/-9 expression by suppressing the
mitogen-activated protein kinase in SK-Hep1 human hepatoma cells.
Food Chem Toxicol. 46:2358–2364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lai KC, Huang AC, Hsu SC, Kuo CL, Yang JS,
Wu SH and Chung JG: Benzyl isothiocyanate (BITC) inhibits migration
and invasion of human colon cancer HT29 cells by inhibiting matrix
metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC
and MAPK signaling pathway. J Agric Food Chem. 58:2935–2942. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hölters S, Anacker J, Jansen L,
Beer-Grondke K, Dürst M and Rubio I: Tetraspanin 1 promotes
invasiveness of cervical cancer cells. Int J Oncol. 43:503–512.
2013.PubMed/NCBI
|
|
21
|
Carloni V, Mazzocca A, Mello T, Galli A
and Capaccioli S: Cell fusion promotes chemoresistance in
metastatic colon carcinoma. Oncogene. 32:2649–2660. 2013.
View Article : Google Scholar
|
|
22
|
Rubinstein E, Le Naour F,
Lagaudrière-Gesbert C, Billard M, Conjeaud H and Boucheix C: CD9,
CD63, CD81, and CD82 are components of a surface tetraspan network
connected to HLA-DR and VLA integrins. Eur J Immunol. 26:2657–2665.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Berditchevski F, Odintsova E, Sawada S and
Gilbert E: Expression of the palmitoylation-deficient CD151 weakens
the association of alpha 3 beta 1 integrin with the
tetraspanin-enriched microdomains and affects integrin-dependent
signaling. J Biol Chem. 277:36991–37000. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen L, Yuan D, Zhao R, Li H and Zhu J:
Suppression of TSPAN1 by RNA interference inhibits proliferation
and invasion of colon cancer cells in vitro. Tumori. 96:744–750.
2010.
|
|
25
|
Ovalle S, Gutiérrez-López MD, Olmo N,
Turnay J, Lizarbe MA, Majano P, Molina-Jiménez F, López-Cabrera M,
Yáñez-Mó M, Sánchez-Madrid F, et al: The tetraspanin CD9 inhibits
the proliferation and tumorigenicity of human colon carcinoma
cells. Int J Cancer. 121:2140–2152. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Friedl P and Alexander S: Cancer invasion
and the microenvironment: Plasticity and reciprocity. Cell.
147:992–1009. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sahai E: Mechanisms of cancer cell
invasion. Curr Opin Genet Dev. 15:87–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang J, Kuang XR, Lv PT and Yan XX:
Thymoquinone inhibits proliferation and invasion of human
nonsmall-cell lung cancer cells via ERK pathway. Tumour Biol.
36:259–269. 2015. View Article : Google Scholar
|
|
29
|
Ang J, Fang BL, Ashman LK and Frauman AG:
The migration and invasion of human prostate cancer cell lines
involves CD151 expression. Oncol Rep. 24:1593–1597. 2010.PubMed/NCBI
|
|
30
|
Longo N, Yáñez-Mó M, Mittelbrunn M, de la
Rosa G, Muñoz ML, Sánchez-Madrid F and Sánchez-Mateos P: Regulatory
role of tetraspanin CD9 in tumor-endothelial cell interaction
during transendothelial invasion of melanoma cells. Blood.
98:3717–3726. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kubben FJ, Sier CF, van Duijn W, Griffioen
G, Hanemaaijer R, van de Velde CJ, van Krieken JH, Lamers CB and
Verspaget HW: Matrix metalloproteinase-2 is a consistent prognostic
factor in gastric cancer. Br J Cancer. 94:1035–1040. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chu D, Zhang Z, Li Y, Zheng J, Dong G,
Wang W and Ji G: Matrix metalloproteinase-9 is associated with
disease-free survival and overall survival in patients with gastric
cancer. Int J Cancer. 129:887–895. 2011. View Article : Google Scholar
|
|
33
|
Tang Y, Zhu J, Chen L, Chen L, Zhang S and
Lin J: Associations of matrix metalloproteinase-9 protein
polymorphisms with lymph node metastasis but not invasion of
gastric cancer. Clin Cancer Res. 14:2870–2877. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Verma S, Kesh K, Gupta A and Swarnakar S:
An overview of matrix metalloproteinase 9 polymorphism and gastric
cancer risk. Asian Pac J Cancer Prev. 16:7393–7400. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Akter H, Park M, Kwon OS, Song EJ, Park WS
and Kang MJ: Activation of matrix metalloproteinase-9 (MMP-9) by
neurotensin promotes cell invasion and migration through ERK
pathway in gastric cancer. Tumour Biol. 36:6053–6062. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guruvayoorappan C and Kuttan G:
Amentoflavone inhibits experimental tumor metastasis through a
regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase,
lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, NM23 and cytokines in
lung tissues of C57BL/6 mice. Immunopharmacol Immunotoxicol.
30:711–727. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Alfano D, Votta G, Schulze A, Downward J,
Caputi M, Stoppelli MP and Iaccarino I: Modulation of cellular
migration and survival by c-Myc through the downregulation of
urokinase (uPA) and uPA receptor. Mol Cell Biol. 30:1838–1851.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ahmad A, Kong D, Wang Z, Sarkar SH,
Banerjee S and Sarkar FH: Down-regulation of uPA and uPAR by
3,3′-diindolylmethane contributes to the inhibition of cell growth
and migration of breast cancer cells. J Cell Biochem. 108:916–925.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ahmad A, Kong D, Sarkar SH, Wang Z,
Banerjee S and Sarkar FH: Inactivation of uPA and its receptor uPAR
by 3,3′-diindolylmethane (DIM) leads to the inhibition of prostate
cancer cell growth and migration. J Cell Biochem. 107:516–527.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Duffy MJ, Maguire TM, McDermott EW and
O'Higgins N: Urokinase plasminogen activator: A prognostic marker
in multiple types of cancer. J Surg Oncol. 71:130–135. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chou YC, Chang MY, Wang MJ, Yu FS, Liu HC,
Harnod T, Hung CH, Lee HT and Chung JG: PEITC inhibits human brain
glioblastoma GBM 8401 cell migration and invasion through the
inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and
-9 gene expression. Oncol Rep. 34:2489–2496. 2015.PubMed/NCBI
|
|
42
|
Ma CY, Ji WT, Chueh FS, Yang JS, Chen PY,
Yu CC and Chung JG: Butein inhibits the migration and invasion of
SK-HEP-1 human hepatocarcinoma cells through suppressing the ERK,
JNK, p38, and uPA signaling multiple pathways. J Agric Food Chem.
59:9032–9038. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hsu HH, Hu WS, Lin YM, Kuo WW, Chen LM,
Chen WK, Hwang JM, Tsai FJ, Liu CJ and Huang CY: JNK suppression is
essential for 17β-estradiol inhibits prostaglandin E2-Induced uPA
and MMP-9 expressions and cell migration in human LoVo colon cancer
cells. J Biomed Sci. 18:612011. View Article : Google Scholar
|
|
44
|
Lin CW, Chen PN, Chen MK, Yang WE, Tang
CH, Yang SF and Hsieh YS: Kaempferol reduces matrix
metalloproteinase-2 expression by down-regulating ERK1/2 and the
activator protein-1 signaling pathways in oral cancer cells. PLoS
One. 8:e808832013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lee SH, Jaganath IB, Manikam R and Sekaran
SD: Inhibition of Raf-MEK-ERK and hypoxia pathways by Phyllanthus
prevents metastasis in human lung (A549) cancer cell line. BMC
Complement Altern Med. 13:2712013. View Article : Google Scholar : PubMed/NCBI
|
